BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7502873)

  • 1. Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.
    Wennerås C; Czerkinsky C; Svennerholm AM
    Adv Exp Med Biol; 1995; 371B():1641-4. PubMed ID: 7502873
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.
    Wennerås C; Svennerholm AM; Czerkinsky C
    Infect Immun; 1994 Mar; 62(3):874-9. PubMed ID: 8112858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea.
    Svennerholm AM; Holmgren J
    Adv Exp Med Biol; 1995; 371B():1623-8. PubMed ID: 7502870
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal enteric colibacillosis of pigs and current research on immunization.
    Kohler EM
    J Am Vet Med Assoc; 1978 Sep; 173(5 Pt 2):588-91. PubMed ID: 359517
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses.
    Liang W; Huang Y; Yang X; Zhou Z; Pan A; Qian B; Huang C; Chen J; Zhang D
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):393-9. PubMed ID: 16553813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral immunization against coli enteritis with streptomycin-dependent E. coli. IV. Tolerance of a streptomycin-dependent O111 B4 bacterial vaccine in infants].
    Köditz H; Kittlick M; Linde K; Koch H
    Zentralbl Bakteriol Orig; 1969; 211(4):486-93. PubMed ID: 4916989
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral immunization against coli enteritis with streptomycin-dependent E. coli. V. Different efficiency of live Sm-d and heat killed E. coli O111 B4 vaccine in settling of the homologous Sm-r strain in mice with antibiotic sterilized intestine].
    Lindek ; Koch H
    Zentralbl Bakteriol Orig; 1970; 215(3):286-95. PubMed ID: 4923787
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy of a recombinant adenoviral based vaccine expressing heat-stable enterotoxin (STa) and K99 adhesion antigen of enterotoxigenic Escherichia coli in mice.
    Deng G; Li W; Wu X; Bao S; Zeng J; Zhao N; Luo M; Liu X; Wang Y
    Mol Immunol; 2015 Dec; 68(2 Pt C):684-91. PubMed ID: 26589454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory studies of the possibility of oral immunization with a sodium desoxycholate extract of dyspepsia coli strains. VII. Serum antibodies in the indirect hemagglutination reaction in immunized and loaded mice].
    Mochmann H; Ocklitz HW; Schmidt EF; Richter U; Hering L
    Zentralbl Bakteriol Orig; 1968; 208(1):58-69. PubMed ID: 4915132
    [No Abstract]   [Full Text] [Related]  

  • 12. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.
    Savarino SJ; Hall ER; Bassily S; Brown FM; Youssef F; Wierzba TF; Peruski L; El-Masry NA; Safwat M; Rao M; El Mohamady H; Abu-Elyazeed R; Naficy A; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD
    J Infect Dis; 1999 Jan; 179(1):107-14. PubMed ID: 9841829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an attenuated strain oral vaccine candidate using a novel double selection platform in Escherichia coli.
    Liu W; Yuan C; Bao J; Guan W; Zhao Z; Li X; Tang J; Li D; Shi D
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):855-67. PubMed ID: 25301580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific oral prevention of infantile gastro-enteritis. I. Experiments in mice.
    Rauss K; Kétyi I; Szendrei L; Vertényi A
    Acta Microbiol Acad Sci Hung; 1970; 17(3):275-84. PubMed ID: 4927397
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.
    Holmgren J; Svennerholm AM
    Scand J Infect Dis Suppl; 1990; 76():47-53. PubMed ID: 2102020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
    Evans DG; Graham DY; Evans DJ
    Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
    Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
    Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral immunization against coli enteritis with streptomycin-dependent E. coli. I. Characterization of streptomycin-dependent vaccinal strains].
    Linde K; Koch H; Kittlick M; Kapell J
    Zentralbl Bakteriol Orig; 1969; 211(4):453-65. PubMed ID: 4916986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.